表皮细胞疗法作为二度烧伤愈合辅助手段:一项随机对照先导研究
这项随机对照先导研究纳入8例患者,每位患者的不同烧伤部位随机接受表皮水疱移植或标准无细胞治疗。表皮移植区愈合略快于无细胞治疗区,红斑更少且更接近周围正常皮肤(p=0.0404),供区不可见且与正常皮肤无差异。作者认为结果支持细胞技术优于无细胞技术,并建议进一步研究更大治疗面积和更大样本量。
要点
- 表皮水疱移植区愈合略快于标准无细胞治疗区。
- 表皮治疗区红斑更少,更接近周围正常皮肤(p=0.0404)。
- 供区不可见且与正常皮肤无可测差异。
核心结论
- 作者认为结果支持细胞技术优于无细胞技术用于部分厚度(2a和2b)烧伤治疗,红斑的显著改善意味着更高质量的愈合过程。
研究设计与样本
- 随机对照先导研究,纳入8例患者,每位患者的不同烧伤部位随机接受表皮水疱移植或标准无细胞治疗。
主要发现
- 表皮水疱移植治疗区愈合略快于无细胞治疗区。
- 表皮治疗区红斑更少,更接近周围正常皮肤(p=0.0404)。
- 供区不可见,且与正常皮肤无可测差异。
关键数值与推荐
- 治疗12个月后采用温哥华瘢痕量表(VSS)、患者与观察者瘢痕评估量表(POSAS)、摄影、光谱测定、Semmes-Weinstein细丝、皮肤弹性测定和高分辨率超声评估结局。
局限性
- 作者指出进一步研究应主要关注更大的治疗面积和更大的样本量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Healing of partial-thickness (2a and 2b) burns is notoriously unpredictable as far as healing time, scarring and (hypo)pigmentation is concerned. Epidermal blister grafting is an autologous grafting technique involving transfer of epidermal islands without dermal elements. Cellutome™ is an FDA-acknowledged epidermal harvesting device. This proof-of-concept study evaluates whether blister grafting of partial-thickness burns results in improved healing compared to standard acellular treatment. METHODS: This is a randomized controlled trial with 8 patients in which each patient received both treatments randomized to different burn sites. Healing was assessed at regular intervals. Twelve months after treatment, outcomes were measured with the Vancouver Scar Scale (VSS), Patient and Observer Scar Assessment Scale (POSAS), photography, spectrometry, Semmes-Weinstein Filaments, cutometry and high-resolution ultrasound. RESULTS: Areas treated with epidermal blister grafting healed slightly faster than acellular treatment. Epidermal treatment yielded healing with less erythema, closer to that of surrounding normal skin (p = 0.0404). Donor sites were not visible and not measurably different than normal skin. CONCLUSIONS: Results favor cellular over acellular technique for the treatment of partial-thickness (2a and 2b) burns. Significant improvement in erythema implies a higher quality healing process. Further studies should look primarily at larger areas of treatment, and larger sample size.
引用
- Blome-Eberwein S, Schwartz A, Pinataro C, et al. Epidermal-cell-based therapy as an adjunct to healing second degree burns-A randomized controlled pilot study. Burns. 2022. PMID: 36195486. doi:10.1016/j.burns.2022.09.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。